Clinical trial
Efficacy and Safety of Fecal Microbiota Transplantation as add-on Therapy in Patients With Mild-To-Moderate Ulcerative Colitis: A Randomized, Clinical Trial
NCT05538026 is registered in ClinicalTrials.gov with Bogomolets National Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Fecal Microbiota Transplantation as add-on Therapy in Patients With Mild-To-Moderate Ulcerative Colitis: A Randomized, Clinical Trial
- Lead sponsor
- Bogomolets National Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- January 10, 2022
- Enrollment
- 53 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases, ulcerative colitis chronic mild